PAREXEL International

Contact
parexel.com

PAREXEL International

The Quays, 101-105 Oxford Road
UB8 1LZ Uxbridge
United Kingdom
parexel.com
Contact
Profile News
Contact

About PAREXEL International

Parexel is focused on the development of innovative new therapies to improve the world's health. We do this by providing a suite of groundbreaking biopharmaceutical development services that help customers across the globe transform scientific discoveries into new treatments for patients. From clinical trial design to regulatory and consulting services to commercial and market access, our therapeutic, technical, and functional ability is underpinned by a deep conviction in what we do.

Read more about PAREXEL International
Facts about PAREXEL International
  • Industry : Pharma

News about PAREXEL International

PAREXEL International

08-Jan-2019 | business & finance

New PAREXEL division supports emerging biotech companies

PAREXEL International Corporation introduced a new, dedicated division to support emerging biotech companies in reaching their drug development and ...

Read news
PAREXEL International

08-Mar-2018 | people

PAREXEL appoints Jamie Macdonald as Chief Executive Officer

Company Co-founder Josef von Rickenbach to retire after 35 years

Read news
PAREXEL International

03-Feb-2017 | business & finance

PAREXEL announces agreement to acquire The Medical Affairs Company

PAREXEL International Corporation, a biopharmaceutical services provider, announced that the Company has entered into a definitive agreement to acquire The ...

Read news
PAREXEL International

18-Feb-2016 | science

Parexel launches expanded genomic research services

Parexel International Corporation announced expanded services and capabilities in genomic-based drug development. The PAREXEL®Genomic Medicine team offers ...

Read news
PAREXEL International

04-Jul-2014 | business & finance

PAREXEL International Announces Acquisition Of ATLAS Medical Services

PAREXEL International Corporation announced that the Company has acquired all of the outstanding equity securities of ATLAS Medical Services, a provider of ...

Read news
PAREXEL International

17-Nov-2011 | business & finance

UCB enters into strategic partnerships in clinical development with PAREXEL and PRA

Strategic partnerships for focused global operational clinical development activities, using complementary strengths and expertise

Read news
PAREXEL International

01-Nov-2005 | research and development

Revotar AG starts supplementary clinical phase-I study with bimosiamose

Revotar Biopharmaceuticals AG announced that it has started a phase-I study with its drug bimosiamose, a pan-selectin antagonist. In this double-blind, ...

Read news
PAREXEL International

29-Apr-2004 | business & finance

PAREXEL Forms Collaboration With Clinical Research Services Provider in India

PAREXEL International Corporation announced that it has entered into an exclusive strategic collaboration with Synchron Research Services Private Limited ...

Read news
Show more news about PAREXEL International

Here you will find PAREXEL International